ERBB2 and breast cancer: Interestingly, POPDC1 was significantly suppressed in the more aggressive breast cancer subtypes, MDA231 triple-negative cells and SKBR3 HER2+ cells, in comparison with non-malignant MCF10A cells (Figure 1).